Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling

Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling

Source: 
BioSpace
snippet: 

In an open letter published Monday, more than 480 biopharma industry leaders, including Pfizer CEO Albert Bourla and former Alnylam founding CEO John Maraganore, expressed their support for the FDA after a Texas federal judge ruled to hold the approval of the abortion pill mifepristone.